These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27575829)

  • 21. Evaluation of online drug references for identifying over-the-counter solid oral dosage forms.
    Weaver SJ; Hatton RC; Doering PL
    J Am Pharm Assoc (2003); 2004; 44(6):694-9. PubMed ID: 15637852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits.
    Davis JM; Severtson SG; Bucher-Bartelson B; Dart RC
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):18-25. PubMed ID: 24130046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electronic pharmacopoeia: a missed opportunity for safe opioid prescribing information?
    Lapoint J; Perrone J; Nelson LS
    J Med Toxicol; 2014 Mar; 10(1):15-8. PubMed ID: 24081616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients.
    Zedler B; Xie L; Wang L; Joyce A; Vick C; Kariburyo F; Rajan P; Baser O; Murrelle L
    Pain Med; 2014 Nov; 15(11):1911-29. PubMed ID: 24931395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costs.
    White AG; LeCates J; Birnbaum HG; Cheng W; Roland CL; Mardekian J
    J Opioid Manag; 2015; 11(3):199-210. PubMed ID: 25985805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overdose Risk in Young Children of Women Prescribed Opioids.
    Finkelstein Y; Macdonald EM; Gonzalez A; Sivilotti MLA; Mamdani MM; Juurlink DN;
    Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28219963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current and future development of extended-release, abuse-deterrent opioid formulations in the United States.
    Webster LR; Markman J; Cone EJ; Niebler G
    Postgrad Med; 2017 Jan; 129(1):102-110. PubMed ID: 27915497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation Strategy.
    Bucher Bartelson B; Le Lait MC; Green JL; Cepeda MS; Coplan PM; Maziere JY; Wedin GP; Dart RC
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1061-1070. PubMed ID: 28758289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical tool to assess reliability of web-based medicines information.
    Lebanova H; Getov I; Grigorov E
    Med Glas (Zenica); 2014 Feb; 11(1):221-7. PubMed ID: 24496368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inadequacies of statutory drug compendia also affect the mental health field.
    Paczynski RP; Kruszewski SP
    Ann Intern Med; 2009 Sep; 151(5):364-5. PubMed ID: 19721028
    [No Abstract]   [Full Text] [Related]  

  • 31. Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics.
    Jann M; Kennedy WK; Lopez G
    J Pharm Pract; 2014 Feb; 27(1):5-16. PubMed ID: 24436437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug Use in the Twittersphere: A Qualitative Contextual Analysis of Tweets About Prescription Drugs.
    Shutler L; Nelson LS; Portelli I; Blachford C; Perrone J
    J Addict Dis; 2015; 34(4):303-10. PubMed ID: 26364675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioids with abuse-deterrent properties: A regulatory and technological overview.
    Haddox JD
    J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription drug misuse: is technology friend or foe?
    Nielsen S; Barratt MJ
    Drug Alcohol Rev; 2009 Jan; 28(1):81-6. PubMed ID: 19320680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Keeping up with drug use and safety.
    Long CO
    Home Healthc Nurse; 2004 Aug; 22(8):530-1. PubMed ID: 15314556
    [No Abstract]   [Full Text] [Related]  

  • 36. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
    Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL
    Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compendia and anticancer therapy under Medicare.
    Tillman K; Burton B; Jacques LB; Phurrough SE
    Ann Intern Med; 2009 Mar; 150(5):348-50. PubMed ID: 19221368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scope, completeness, and accuracy of drug information in Wikipedia.
    Clauson KA; Polen HH; Boulos MN; Dzenowagis JH
    Ann Pharmacother; 2008 Dec; 42(12):1814-21. PubMed ID: 19017825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical review on the abuse and misuse potential of tramadol and tilidine in Germany.
    Radbruch L; Glaeske G; Grond S; Münchberg F; Scherbaum N; Storz E; Tholen K; Zagermann-Muncke P; Zieglgänsberger W; Hoffmann-Menzel H; Greve H; Cremer-Schaeffer P
    Subst Abus; 2013; 34(3):313-20. PubMed ID: 23844964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of medicines information for patient safety.
    Pappa D; Telonis P; Stergioulas LK
    J Telemed Telecare; 2006; 12 Suppl 1():34-6. PubMed ID: 16884574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.